Intelence Oral Tablet 100Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

INTELENCE: Oral tablet (100mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_10480.JPG
INTELENCE 100mg Tablet
Janssen Therapeutics, Division of Janssen Products, LP
Pill Identification: TMC125  |  100

What is this Medicine?

ETRAVIRINE (E tra VIR een) is an antiretroviral medicine. It is used with other medicines to treat HIV. This medicine is not a cure for HIV. It will not stop the spread of HIV to others.

CVS Pharmacy Patient Statistics for INTELENCE: Oral tablet(100mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

INTELENCE 100mg Tablet

NDC: 596760570
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Human Immunodeficiency Virus (HIV) Infection

Sometimes used for but not FDA approved for the following conditions:
Human Immunodeficiency Virus (HIV) Prophylaxis

Storage Information
Store in original container
Protect from moisture
Store at 77 degrees F; excursions permitted to 59-86 degrees F
INTELENCE 100mg Tablet
Drug Image file DrugItem_10480.JPG
Janssen Therapeutics, Division of Janssen Products, LP
Pill Identification: TMC125  |  100
Shape: oval
Color: white

Reported Side Effects for INTELENCE 100mg Tablet

Heart Attack Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Inflamed Pancreas Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Breakdown Of Muscle Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Convulsions Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Brain Attack Incidence:
<0.5%*
Severity: SEVERE
Onset: EARLY
Fainting Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Loss Of Memory Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Blurred Vision Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Breathing Difficulties Incidence:
<2.0%*
Severity: SEVERE
Onset: RAPID
Confusion Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Conjunctivitis Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
<6.0%*
Severity: MODERATE
Onset: DELAYED
Heartburn Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Gynecomastia Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Vomiting Of Blood Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Liver Failure Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Enlarged Liver Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Hypoesthesia Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Fat Redistribution Incidence:
<0.5%*
Severity: MODERATE
Onset: DELAYED
Nightmares Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Paresthesias Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Kidney Failure Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Fatty Change Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Lyell'S Syndrome Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Night Sweats Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Erythema Multiforme Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Drowsiness Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Gas Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Diabetes Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Hemolytic Anemia Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Constipation Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Irregular Heart Beat Incidence:
<2.0%*
Severity: SEVERE
Onset: EARLY
Excessive Sweating Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Nervousness Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Decreased Appetite Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Stevens-Johnson Syndrome Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Mouth Ulcers Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Low Platelet Count Incidence:
<3.0%*
Severity: MODERATE
Onset: DELAYED
Shaking Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Balance Problems Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Dry Skin Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Dry Mouth Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Liver Infection Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Fats Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Anemia Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Stomach Incidence:
>1.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
1.0-2.0%*
Severity: MODERATE
Onset: DELAYED
High Amylase Levels Incidence:
2.0-7.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
>2.0%*
Severity: MILD
Onset: EARLY
Low White Blood Cells Incidence:
2.0-5.0%*
Severity: MODERATE
Onset: DELAYED
High Triglycerides Incidence:
4.0-9.0%*
Severity: MODERATE
Onset: DELAYED
Nerve Pain Incidence:
4.0%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Sugar Incidence:
4.0-15.0%*
Severity: MODERATE
Onset: DELAYED
High Bilirubin Level Incidence:
7.1%*
Severity: MODERATE
Onset: DELAYED
High Cholesterol Incidence:
8.0-20.0%*
Severity: MODERATE
Onset: DELAYED
Skin Rash Incidence:
10.0-15.0%*
Severity: MILD
Onset: EARLY
Rash With Pustules Incidence:
15.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for INTELENCE 100mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Marijuana and INTELENCE 100mg Tablet(Etravirine)
Marijuana and Non-nucleoside reverse transcriptase inhibitors(Etravirine)
Although an interaction is possible, these drugs may be used together. In therory, side effects from Marijuana, Medical may get worse if you take Anti-retroviral non-nucleoside reverse transcriptase inhibitors (NNRTIs). However, the importance of this interaction is not known. Notify your health care provider if you notice increased fatigue, nausea, vomiting, or any other unusual effects.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with INTELENCE

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5